Abstract:BACKGROUND: Bone marrow mesenchymal stem cells (BMSCs) can differentiate into hepatocyte-like cells in vivo and vitro and show hepatocyte function such as synthesis and secretion. OBJECTIVE: To induce and differentiate BMSCs into hepatic cells, which are transplanted into homogeneitic rat livers that had fibrous degenerated, and to observe the distribution, differentiation and effects of the hepatocytes on hepatic function. DESIGN, TIME AND SETTING: Randomized controlled animal experiment was performed at the Laboratory of Hospital Affiliated to Luzhou Medical College from June 2007 to March 2008. MATERIALS: A total of 10 clean male Sprague Dawley rats weighing 100 g were selected to culture BMSCs and to be induced and differentiated into hepatocyte-like cells. A total of 75 clean male Sprague Dawley rats weighing 200-250 g were randomly divided into hepatocyte-like cell transplantation group (n=30), model control group (n=30) and normal control group (n=15). Rats in the hepatocyte-like cell transplantation group and model control group intraperitonealy underwent carbon tetrachloride to prepare animal models of hepatic fibrosis. METHODS: Rats in the model control group and normal control group were subjected to serum-free low-glucose DMEM via portal vein infusion. Rats in the hepatocyte-like cell transplantation group received DAPI labelled hepatocyte-like cells. All rats were sacrificed to obtain liver and serum samples at 1, 2, 3 and 4 weeks following transplantation. MAIN OUTCOME MEASURES: Degree of the hepatic fibrosis was evaluated though Masson triple stain. Frozen sections were made to detect transformation of livers which had been transplanted cells with a fluorescence microscope. Serum the parameters of liver function and hepatic fibrosis were detected by the automatic biochemistry analyzer and radio-immunifaction method. RESULTS: Transplanted cells from the blood vessels gradually accessed into the liver, and eventually distributed between the liver cells scattered. But after three weeks of transplantation, fluorescence obviously decayed. At week 2, liver false lobular gradually absorbed or dissipated, and fibrosis significantly milder than the model control group, with collagen staining lighting and distributing in the fiber interval and portal area, and liver cells presented Balloon-like degeneration. At week 4, liver cells arranged in normal. Dot necrosis was occasionally found without fiber interval. No significant differences in the parameters of liver function and hepatic fibrosis were found compared with the normal control group(P > 0.05). CONCLUSION: Induced hepatocyte-like cells could engraft into fibrotic liver after transfusion as early as on the 7th day and localized in collection tube region and liver sinus. Results of biochemistry detection showed that the engrafted hepatocyte-like cells could substitute liver function partly.

Pig Bone Marrow Stromal Cells Transfected with Human Tissue Factor Pathway Inhibitor Combat Species Incompatibility and Regulate the Human TF Pathway in Vitro

Pig BMSCs Transfected with Human TFPI Combat Species Incompatibility and Regulate the Human TF Pathway in Vitro and in a Rodent Model

Human bone marrow mesenchymal stem cell-derived hepatocytes express tissue inhibitor of metalloproteinases 4 and follistatin

Mutational analysis of pig tissue factor pathway inhibitor α to increase anti-coagulation activity in pig-to-human xenotransplantation

Establishment and Characterization of Immortalized Porcine Hepatocytes for the Study of Hepatocyte Xenotransplantation.

Improved hepatic microcirculation by human soluble urinary thrombomodulin in the xeno-perfused porcine liver

Genetically modified bone marrow mesenehymal stem cells can regulate the coagulation in an in vitro model of xenotransplantation clotting disorders

Stable expression of the human thrombomodulin transgene in pig endothelial cells is associated with a reduction in the inflammatory response

Immortalization of porcine hepatocyte lines by transfection with simian virus 40 large T antigen and human telomerase reverse transcriptase

Transplantation of Bone Marrow Mesenchymal Stromal Cells Attenuates Liver Fibrosis in Mice by Regulating Macrophage Subtypes

Study on SCARB1 mediated coagulation dysregulation in recipients after liver xenotransplantation

Immediate Intraportal Transplantation of Human Bone Marrow Mesenchymal Stem Cells Prevents Death from Fulminant Hepatic Failure in Pigs

Quantitative evaluation of human bone mesenchymal stem cells rescuing fulminant hepatic failure in pigs

Intrasplenic co-transplantation of fetal hepatic progenitor cells and transforming growth factor beta 1 induced hepatic stellate cells ameliorates acute liver injury

Studies on Coagulation Incompatibilities for Xenotransplantation

Return of the Metabolic Trajectory to the Original Area after Human Bone Marrow Mesenchymal Stem Cell Transplantation for the Treatment of Fulminant Hepatic Failure

Transplantation of bone marrow-derived hepatocyte-like cells via the portal vein in rat hepatic fibrosis models

Humanized von Willebrand factor reduces platelet sequestration in ex vivo and in vivo xenotransplant models

Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation

hEPCR.hTBM.hCD47.hHO‐1 with donor clodronate and DDAVP treatment improves perfusion and function of GalTKO.hCD46 porcine livers perfused with human blood

Repair of Tissue Injury in Transplantation Region of Model Rats with Xenogenic Liver Transplant by Murine Bone Marrow-derived Mesenchymal Stem Cells